Skip to main content
OpenTrials

Clinical trial condition

Hyperparathyroidism

Explore clinical trials studying Hyperparathyroidism. Study availability and eligibility vary by location and protocol.

234 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Hyperparathyroidism trial results

Completed

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

NCT01785849

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Pine Bluff, Arkansas, United States
  • Research Site Azusa, California, United States
  • Research Site Covina, California, United States
View all 118 locations
View Trial Details
Completed

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

NCT01788046

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Azusa, California, United States
  • Research Site Beverly Hills, California, United States
  • Research Site Chula Vista, California, United States
View all 106 locations
View Trial Details
Completed

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

NCT01896232

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations
  • Research Site Azusa, California, United States
  • Research Site Bakersfield, California, United States
  • Research Site Bakersfield, California, United States
  • Research Site Chula Vista, California, United States
View all 182 locations
View Trial Details
Completed

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

NCT02833857

Conditions
Chronic Disease, Chronic Kidney Disease, Secondary Hyperparathyroidism, Disease Attributes, +14 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Louisville, Kentucky, United States
  • Research Site Kansas City, Missouri, United States
  • Research Site Brussels, Belgium
View all 13 locations
View Trial Details
Completed

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

NCT01785875

Conditions
Calcium Metabolism Disorders, Chronic Disease, Disease Attributes, +18 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Pine Bluff, Arkansas, United States
  • Research Site Azusa, California, United States
  • Research Site Bakersfield, California, United States
View all 208 locations
View Trial Details

Related conditions